Deutsche Märkte schließen in 7 Stunden 11 Minuten

Pieris Pharmaceuticals, Inc. (PI6.F)

Frankfurt - Frankfurt Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
0,12580,0000 (0,00%)
Ab 08:00AM CEST. Markt geöffnet.
Hauptinhaber
Insider

Insider-Transaktionen

Währung in EUR
Insider-Käufe (letzte 6 Monate)AktienTrans
Käufe00
VerkaufN/A0
Gekaufte Nettoaktien (verkauft)00
Insideraktien mit Beteiligung (gesamt)91,95kN/A
% Gekaufte Nettoaktien (verkauft)N/AN/A
Institutionelle Käufe (netto) der letzten QuartaleAktien
Gekaufte Nettoaktien (verkauft)N/A
% Schwankung in institutioneller AktienbeteiligungN/A

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

InsiderTransaktionTypWertDatumAktien

KIRITSY CHRISTOPHER P
Director

Purchase at price 0.85 per share.Direkt8.50025. Mai 202310.000

DEMUTH TIM
Officer

Purchase at price 1.71 per share.Direkt10.26013. Mai 20226.000

OLWILL SHANE
Officer

Sale at price 5.00 - 5.15 per share.Direkt196.38030. Aug. 202138.400

OLWILL SHANE
Officer

Conversion of Exercise of derivative security at price 1.52 per share.Direkt58.36830. Aug. 202138.400

AQUILO CAPITAL MANAGEMENT, LLC
Beneficial Owner of more than 10% of a Class of Security

Sale at price 2.95 per share.Indirekt5.605.00021. Juli 20201.900.000

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Sale at price 4.50 per share.Indirekt224.97006. Sept. 201950.000

KIRITSY CHRISTOPHER P
Director

Purchase at price 5.11 per share.Direkt25.52514. Sept. 20185.000

GERAGHTY JAMES A.
Director

Purchase at price 5.75 per share.Direkt57.50015. Mai 201810.000

ORBIMED ADVISORS, L.L.C.
Shareholder

Sale at price 6.35 per share.Indirekt6.350.00030. Apr. 20181.000.000

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 8.98 per share.Indirekt70.91513. Feb. 20187.897

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 4.68 - 5.08 per share.Indirekt37.67113. Feb. 20187.897

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 7.35 per share.Indirekt12.565.70703. Jan. 20181.709.620

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 5.70 per share.Indirekt841.52018. Dez. 2017147.635

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Conversion of Exercise of derivative security at price 1.59 - 5.64 per share.Indirekt308.05218. Dez. 2017147.635

GERAGHTY JAMES A.
Director

Purchase at price 4.82 per share.Direkt48.20017. Aug. 201710.000

REINE ALLAN
Chief Financial Officer

Purchase at price 4.79 - 4.89 per share.Direkt313.35017. Aug. 201765.000

KIRITSY CHRISTOPHER P
Director

Conversion of Exercise of derivative security at price 1.59 per share.Direkt7.95021. Apr. 20175.000

MATIS LOUIS A. M.D.
Officer

Purchase at price 1.68 - 1.71 per share.Direkt17.03714. Juni 201610.000

DEPTULA-HICKS DARLENE M
Chief Financial Officer

Purchase at price 1.66 per share.Direkt8.30013. Juni 20165.000

YODER STEPHEN S
Chief Executive Officer

Purchase at price 1.68 per share.Direkt10.08013. Juni 20166.000

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 2.75 per share.Indirekt1.375.00006. Juli 2015500.000

KHUONG CHAU QUANG
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 2.75 per share.Indirekt1.375.00006. Juli 2015500.000